Litigation Details for Sebela International Limited v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
✉ Email this page to a colleague
Sebela International Limited v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-06-28 |
Court | District Court, D. New Jersey | Date Terminated | 2018-02-07 |
Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
Jury Demand | Plaintiff | Referred To | Mark Falk |
Parties | SEBELA PHARMACEUTICALS INC. | ||
Patents | 6,113,944; 8,658,663; 8,946,251; 9,393,237 | ||
Attorneys | LIZA M. WALSH | ||
Firms | Foley & Lardner LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Sebela International Limited v. ACTAVIS LABORATORIES FL, INC.
Details for Sebela International Limited v. ACTAVIS LABORATORIES FL, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-06-28 | 1 | A - Brisdelle label, # 2 Exhibit B - U.S. Patent 9,393,237, # 3 Exhibit C - Actavis ANDA label, # 4 Form…2017 8 February 2018 2:17-cv-04789 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
2017-07-07 | 11 | U.S. Patent No. 9,393,237, # 4 Exhibit 3: U.S. Patent No. 8,658,663, # 5 Exhibit 4: U.S. Patent No. 8,946,251…2017 8 February 2018 2:17-cv-04789 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
2017-07-25 | 24 | U.S. Patent No. 5,955,475, # 3 Exhibit 35: U.S. Patent No. 6,113,944, # 4 Exhibit 36: U.S. Patent No. …6,645,523, # 5 Exhibit 37: U.S. Patent No. 6,660,298, # 6 Exhibit 38: U.S. Patent No. 6,699,882, # 7 Exhibit…40: U.S. Patent Application Publication No. 2004/0067254 (Lemmens), # 9 Exhibit 41: U.S. Patent No. 6,369,051…2017 8 February 2018 2:17-cv-04789 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |